Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Summary of Stock Option Activities (Details)

v3.22.2.2
Stock-Based Compensation - Summary of Stock Option Activities (Details) - Options
$ / shares in Units, $ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Options    
Outstanding - beginning balance (in shares) | shares 8,084,676  
Granted (in shares) | shares 0  
Exercised (in shares) | shares (450,143)  
Forfeited (in shares) | shares 0  
Outstanding - ending balance (in shares) | shares 7,634,533 8,084,676
Exercisable at period end (in shares) | shares 7,634,533  
Weighted Average Exercise Price    
Outstanding - beginning balance (in dollars per share) $ 0.19  
Granted (in dollars per share) 0  
Exercised (in dollars per share) 0.18  
Forfeited (in dollars per share) 0  
Outstanding - ending balance (in dollars per share) 0.19 $ 0.19
Exercisable at period end (in dollars per share) 0.19  
Weighted Average Grant Date Fair Value    
Outstanding - beginning balance (in dollars per share) 0.21  
Granted (in dollars per share) 0  
Exercised (in dollars per share) 0.22  
Forfeited (in dollars per share) 0  
Outstanding - ending balance (in dollars per share) 0.21 $ 0.21
Exercisable at period end (in dollars per share) $ 0.21  
Additional Disclosures    
Weighted Average Remaining Life (years) 4 years 9 months 18 days 5 years 7 months 6 days
Weighted Average Remaining Life, Exercisable (years) 4 years 9 months 18 days  
Intrinsic Value | $ $ 29,335 $ 69,875
Intrinsic Value, Exercisable | $ $ 29,335